Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence Tomography

The purpose of the present study is to determine if the retinal thickness estimates of the Stratus OCT, the 3D OCT-1000, and the CirrusHD OCT are comparable in diabetic and in healthy individuals (OCT=Optical Coherence Tomography).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Diabetic Maculopathy

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Nordre Ringvej 57

Glostrup Municipality, Copenhagen, DK-2600, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

diabetic retinopathy in the diabetic group
healthy retinas in the healthy group

Exclusion criteria

not able to cooperate
retinal disease other than macular oedema
severe media opacities (e.g. cataract)
prior macular laser photocoagulation except for large oedemas

Treatment and study plan

optical coherence tomography

Device

Stratus OCT: fast radial lines 3D OCT-1000: radial 2048 and 3D OCT Cirrus HD OCT: 3D OCT

Primary outcomes

Retinal thickness and retinal volume from each OCT scan

Time frame: within 24 hours

Sponsors and collaborators

Lead sponsor

Glostrup University Hospital, Copenhagen

Other

Registry information

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Apr 1, 2009
Registry last updated: Sep 6, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed